Evaluation of Intravenous Nitrite Infusion for Reversal of Cerebral Vasospasm After Subarachnoid Hemorrhage From a Cerebral Aneurysm
Phase of Trial: Phase II
Latest Information Update: 01 Apr 2018
Price : $35 *
At a glance
- Drugs Sodium nitrite (Primary)
- Indications Subarachnoid haemorrhage
- Focus Therapeutic Use
- Sponsors Hope Pharmaceuticals
- 09 May 2017 Status changed from recruiting to discontinued.
- 26 Feb 2016 Planned primary completion date changed from 1 Dec 2016 to 1 Dec 2017, according to ClinicalTrials.gov record.
- 21 Jul 2014 New trial record